Medyczne konopie

EN_01508903_0016

30,00 EUR Private use
Making print for private purpose, storage in computer memory, no distribution rights.
40,00 EUR Internet - private use
Strictly for editorial, single use on a personal (nonprofit) web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
75,00 EUR Internet commercial use
Strictly for editorial, single use on a commercial web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
90,00 EUR Print use
Strictly for editorial, single use, inside of newspaper, magazine, book (including digital version), one edition, one single country. Not for resale.

Gross prices

caption

8 janvier 2022. LaFleur cree par Franck Milone est un laboratoire francais de l innovation vegetale a Angers, qui developpe des medicaments aux standards pharmaceutiques. LaFleur mene des etudes sur la recherche sur le cannabis avec des institutions de recherche universitaires et des laboratoires prives et publics et est engage dans des projets de recherche sur la selection varietale, la standardisation de la production de fleurs de cannabis. En 2022, le laboratoire va mettre en place un essai clinique precoce et en 2023, il commercialisera les premiers produits de sante a base de cannabis a visee therapeutique 100 pourcents fabriques en France. Angers, 14/01/2022 January 8, 2022. LaFleur created by Franck Milone is a French laboratory of plant innovation located in Angers, which develops medicines to pharmaceutical standards. LaFleur conducts studies on cannabis research with academic research institutions and private and public laboratories and is engaged in research projects on varietal selection, standardization of cannabis flower production. In 2022, the laboratory will set up an early clinical trial and in 2023, it will market the first health products based on 100 percent therapeutic cannabis manufactured in France. Angers, 01/14/2022//04HARSIN_CANNABISLABORATOIRELAFLEUR002/2201141530

headline Medyczne konopie

created date 2022-01-14

credit ISA HARSIN/SIPA/SIPA/East News

source SIPA

byline ISA HARSIN/SIPA

original transmission reference SIPA.01056382000002

weight 1,54MB

size 25cm x 17cm by 300dpi

keywords - Show

01, 04HARSIN, 100, 14, 2022, 2023, 8, A, ACADEMIC, AN, AND, ANGERS, ANSM, AUX, AVEC, BASE, BASED, BY, CANNABIDIOL, CANNABIS, CBD, CLINICAL, CLINIQUE, COMMERCIALISERA, CONDUCTS, CREATED, CREE, DANS, DE, DES, DEVELOPPE, DEVELOPS, EARLY, EN, ENGAGE, ENGAGED, ESSAI, EST, ET, ETUDES, FABRIQUES, FIRST, FLEURS, FLOWER, FRANCAIS, FRANCE, FRANCK, FRENCH, HARSIN, HEALTH, IL, IN, INNOVATION, INSTITUTIONS, IS, ISA, IT, JANUARY, JANVIER, L, LA, LABORATOIRE, LABORATOIRES, LABORATORIES, LABORATORY, LAFLEUR, LE, LES, LOCATED, M, MANUFACTURED, MARKET, MEDICAMENTS, MEDICINES, MENE, METTRE, MILONE, OF, ON, PAR, PERCENT, PHARMACEUTICAL, PHARMACEUTIQUES, PLACE, PLANT, POURCENTS, PRECOCE, PREMIERS, PRIVATE, PRIVES, PRODUCTION, PRODUCTS, PRODUITS, PROJECTS, PROJETS, PUBLIC, PUBLICS, QUI, RECHERCHE, RESEARCH, SANTE, SELECTION, SET, STANDARDISATION, STANDARDIZATION, STANDARDS, STUDIES, SUR, THC, THE, THERAPEUTIC, THERAPEUTIQUE, TO, TRIAL, UN, UNIVERSITAIRES, UP, VA, VARIETAL, VARIETALE, VEGETALE, VISEE, WHICH, WILL, WITH,